Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Code Securities was a prominent UK-based specialist investment bank dedicated exclusively to the healthcare and life sciences sectors. Established in 2003 by a team of experienced healthcare bankers and clinicians, the firm provided corporate finance, mergers and acquisitions advisory, and equity brokerage services to biotech and medtech companies. The firm was highly regarded for its deep technical expertise, often employing professionals with clinical backgrounds to provide nuanced valuation and strategic advice. In 2005, the company was acquired by Nomura Holdings to form Nomura Code Securities, serving as the cornerstone of Nomura's European healthcare investment banking franchise. The entity played a significant role in numerous high-profile European life science transactions before its eventual integration and closure in 2013.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Code Securities.